Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Fistula clinical trials

1 of 5 indexed Fistula trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Fistula: 5 US clinical trials tracked, 1 recruiting.

Fistula is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Renal Research Institute, running 1 of these trials.

Enrollment posture brief

Registry condition fistula

OPEN 1 | RECR 20% | LATE 0 | EARLY 0 | RANK #3391 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Fistula (this)20%
Open-enrollment share among volume-matched conditions near Fistula

Fistula lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Fistula on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Fistula is recruiting below its size-band peers.

    1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Fistula research.

    Renal Research Institute accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Fistula enrolment sits around 240 participants.

    Median target enrolment is 240 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.

  4. Fistula research leans observational.

    1 interventional and 4 observational studies make up this index (20% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Top Sponsors

Medtronic 1 trials
AdventHealth 1 trials
Takeda 1 trials

Named interventions

Most-linked intervention names on Fistula records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Ellipsys Vascular Access Catheter Device
1 trials
IN.PACT™ AV Drug Coated Balloon (DCB) - Extended Cohort Combination
1 trials
IN.PACT™ AV Drug Coated Balloon (DCB) - Primary Cohort Combination
1 trials
DAT Clip Device
1 trials

US sites by state

Facility locations filed on Fistula trials. A trial with sites in several states counts in each.

New York 3 trials
Florida 3 trials
California 3 trials
Virginia 2 trials
Texas 2 trials
Pennsylvania 2 trials
North Carolina 2 trials
Wisconsin 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Fistula page

5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Fistula condition card totals 5 registered trials; most-linked intervention Ellipsys Vascular Access Catheter; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.